Search Results - "Fonteneau, Jean‐François"
-
1
Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development
Published in Cancer letters (01-06-2021)“…Early events in an experimental model of mesothelioma development include increased levels of editing in double-stranded RNA (dsRNA). We hypothesised that…”
Get full text
Journal Article -
2
Measles Virus Vaccine―Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
Published in Clinical cancer research (01-03-2013)“…Plasmacytoid dendritic cells (pDC) are antigen-presenting cells specialized in antiviral response. The measles virus vaccine is proposed as an antitumor agent…”
Get full text
Journal Article -
3
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy
Published in Respiratory research (05-04-2024)“…Lung cancers represent the main cause of cancer related-death worldwide. Recently, immunotherapy alone or in combination with chemotherapy has deeply impacted…”
Get full text
Journal Article -
4
A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming
Published in The Journal of immunology (1950) (15-02-2014)“…Peptide splicing is a novel mechanism of production of peptides relying on the proteasome and involving the linkage of fragments originally distant in the…”
Get full text
Journal Article -
5
Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells
Published in Journal of Virology (01-05-2004)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
6
Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy
Published in Frontiers in oncology (24-06-2021)“…Homozygous deletion (HD) of the tumor suppressor gene CDKN2A is the most frequent genetic alteration in malignant pleural mesothelioma and is also frequent in…”
Get full text
Journal Article -
7
The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles
Published in Frontiers in immunology (28-07-2022)“…DCMU [N-(3,4-dichlorophenyl)-N-dimethylurea] or diuron is a widely used herbicide, which can cause adverse effects on human, especially on immune cells, due to…”
Get full text
Journal Article -
8
Loss of miR-200c-3p promotes resistance to radiation therapy via the DNA repair pathway in prostate cancer
Published in Cell death & disease (16-10-2024)“…Radiotherapy represents a major curative treatment for prostate cancer (PCa), but some patients will develop radioresistance (RR) and relapse. The underlying…”
Get full text
Journal Article -
9
Activation of influenza virus–specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity
Published in Blood (01-05-2003)“…Plasmacytoid dendritic cells (pDCs) contribute to innate antiviral immune responses by producing type I interferons (IFNs) upon exposure to enveloped viruses…”
Get full text
Journal Article -
10
A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2020)“…Oncolytic immunotherapy efficacy relies partially on the induction of immunogenic tumor cell death following infection with oncolytic viruses (OV) to induce an…”
Get more information
Journal Article -
11
MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge
Published in BioMed research international (01-01-2013)“…MUC1 glycoprotein is often found overexpressed and hypoglycosylated in tumor cells from numerous cancer types. Since its discovery MUC1 has been an attractive…”
Get full text
Journal Article -
12
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
Published in Journal for immunotherapy of cancer (01-06-2020)“…BackgroundMalignant pleural mesothelioma (MPM) is a rare and aggressive cancer related to asbestos exposure. The tumor microenvironment content, particularly…”
Get full text
Journal Article -
13
Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment
Published in Oncoimmunology (31-12-2024)“…Attenuated measles virus (MV) exerts its oncolytic activity in malignant pleural mesothelioma (MPM) cells that lack type-I interferon (IFN-I) production or…”
Get full text
Journal Article -
14
Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
Published in Oncotarget (29-12-2015)“…Attenuated measles virus (MV) is currently being evaluated as an oncolytic virus in clinical trials and could represent a new therapeutic approach for…”
Get full text
Journal Article -
15
Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways
Published in Stem cell research & therapy (10-01-2022)“…Muscular dystrophies (MDs) are inherited diseases in which a dysregulation of the immune response exacerbates disease severity and are characterized by…”
Get full text
Journal Article -
16
Viral cancer therapies: are they ready for combination with other immunotherapies?
Published in Future oncology (London, England) (01-08-2017)“…Due to their ability to specifically target and kill cancer cells without replicating in the healthy ones, they have been extensively studied over the last two…”
Get full text
Journal Article -
17
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells
Published in Oncoimmunology (04-03-2018)“…Oncolytic immunotherapy using oncolytic viruses (OV) has been shown to stimulate the antitumor immune response by inducing the release of tumor-associated…”
Get full text
Journal Article -
18
Downregulation of MUC1 expression and its recognition by CD8+ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi
Published in European journal of immunology (01-03-2012)“…Research into new treatments against malignant pleural mesothelioma (MPM) is of great interest, as this aggressive cancer is often resistant to conventional…”
Get full text
Journal Article -
19
Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity
Published in Molecular Therapy: Oncology (19-12-2024)“…Extracellular vesicles (EVs) are mediators of intercellular communication in the tumor microenvironment. Tumor EVs are commonly associated with metastasis,…”
Get full text
Journal Article -
20
Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma
Published in JTO clinical and research reports (01-12-2022)“…The aim of this study was to investigate endogenous retrovirus (ERV) expression and type I interferon (IFN) activation in human pleural mesothelioma (PM) and…”
Get full text
Journal Article